| http://www.w3.org/ns/prov#value | - Consideration can be given to discontinuing secondary CMV prophylaxis in adults with sustained (e.g., for ???6 months) increase in CD4+ T-cell counts to >100???150/mm3 in response to potent antiretroviral therapy.317 This decision should be made in consultation with an ophthalmologist and factors such as the magnitude and duration of CD4+ T-cell increase, anatomic location of the retinal lesion, v
|
